Search research articles
Contact Us
Filters
Showing results (1181-1190 of 1,206) with videos related to
Page
of 121
Sort By:
Cancers
|
December 7, 2019
Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer
Yen-Liang Liu, Aaron M Horning, Brandon Lieberman, et al.
Cell Reports
|
September 2, 2023
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages
Chia-Nung Hung, Meizhen Chen, Daniel T DeArmond, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 11, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
Chao-Hua Chiu, Cheng-Ta Yang, Jin-Yuan Shih, et al.
Nature Genetics
|
September 16, 2003
Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource
Wei Hu, Qing Yan, Da-Kang Shen, et al.
Cancer Research
|
January 30, 2020
Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer
Josephine A Taverna, Chia-Nung Hung, Daniel T DeArmond, et al.
NPJ Digital Medicine
|
October 9, 2021
A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
Sercan Ö Arık, Joel Shor, Rajarishi Sinha, et al.
Journal of Ethnopharmacology
|
April 10, 2022
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial
Huan-Ming Xiao, Mei-Jie Shi, Jun-Min Jiang, et al.
JTO Clinical and Research Reports
|
January 29, 2025
Durvalumab, Tremelimumab, and Platinum Chemotherapy in <i>EGFR</i> Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)
Chee Khoon Lee, Bin-Chi Liao, Shalini Subramaniam, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 1, 2024
PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2
Chun-Liang Yang, Fa-Xi Wang, Jia-Hui Luo, et al.
JAMA Internal Medicine
|
September 10, 2020
Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial
Lin-Ling Cheng, Wei-Jie Guan, Chong-Yang Duan, et al.
Page
of 121
Search research articles
Search
Showing results (1181-1190 of 1,206) with videos related to
Sort By:
Page
of 121
Cancers
|
December 7, 2019
Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer
Yen-Liang Liu, Aaron M Horning, Brandon Lieberman, et al.
Cell Reports
|
September 2, 2023
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages
Chia-Nung Hung, Meizhen Chen, Daniel T DeArmond, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 11, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
Chao-Hua Chiu, Cheng-Ta Yang, Jin-Yuan Shih, et al.
Nature Genetics
|
September 16, 2003
Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource
Wei Hu, Qing Yan, Da-Kang Shen, et al.
Cancer Research
|
January 30, 2020
Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer
Josephine A Taverna, Chia-Nung Hung, Daniel T DeArmond, et al.
NPJ Digital Medicine
|
October 9, 2021
A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
Sercan Ö Arık, Joel Shor, Rajarishi Sinha, et al.
Journal of Ethnopharmacology
|
April 10, 2022
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial
Huan-Ming Xiao, Mei-Jie Shi, Jun-Min Jiang, et al.
JTO Clinical and Research Reports
|
January 29, 2025
Durvalumab, Tremelimumab, and Platinum Chemotherapy in <i>EGFR</i> Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)
Chee Khoon Lee, Bin-Chi Liao, Shalini Subramaniam, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 1, 2024
PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2
Chun-Liang Yang, Fa-Xi Wang, Jia-Hui Luo, et al.
JAMA Internal Medicine
|
September 10, 2020
Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial
Lin-Ling Cheng, Wei-Jie Guan, Chong-Yang Duan, et al.
Page
of 121